Blood Culture Tests Market Worth $6.6 Billion by 2025 | CAGR: 8.6%: Grand View Research, Inc.

News provided by

Grand View Research

22 May, 2017, 09:00 GMT

SAN FRANCISCO, May 22, 2017 /PRNewswire/ --

The global blood culture tests market is expected to reach USD 6.6 billion by the year 2025, according to a new report by Grand View Research, Inc. The increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the market growth during the forecast period. Increasing demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is the main factor that drives growth of the market. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables.

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

The introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to CDC, there was 46% decrease in central line-associated bloodstream infections between 2008 and 2013 in the U.S., owing to efforts taken by the U.S. government for the prevention of hospital-acquired infections.

Browse full research report with TOC on "Blood Culture Test Market By Product (Consumables, Instruments), By Technology (Culture-Based Technology), By Application, By Technique, By End-use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market

Further key findings from the report suggest: 

  • Conventional blood culture technique is the largest revenue-grossing segment owing to huge applications of this method in hospitals, independent clinical laboratories, and pathology laboratories
  • In the product segment, consumables accounted for the largest revenue share in 2016, due their huge applications in diagnostics & research, with repetitive purchase of these consumables, such as blood culture media, assay, kits, and reagents, adding to the revenue
  • Automated blood culture systems segment is the fastest growing segment of the blood culture tests market owing to the advantages of automation, such as low chances of error, faster result generation, etc.
  • Molecular technology segment is projected to grow at the highest CAGR, because of increasing demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases
  • Bacterial infections accounted for the largest revenue share in 2016, due to the fact that they are the most common cause for infection in the blood
  • Reference laboratories is projected to grow at the highest rate during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories
  • North America is the leading regional sector that accounted for the largest revenue share of the blood culture tests market in 2016, because of the presence of well-developed healthcare infrastructure in this region
  • The Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases
  • Some of the major players are Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche Diagnostics; Bruker Corporation; Abbott Laboratories; and Alere

Browse related reports by Grand View Research: 

Grand View Research has segmented the global blood culture tests market on the basis of product, technique, technology, application, end-use, and region: 

  • Blood Culture Tests Product Outlook (Revenue, USD Million; 2014 - 2025) 
    • Consumables
      • Blood culture media
        • Aerobic blood culture media
        • Anaerobic blood culture media
        • Fungi/yeast blood culture media
        • Others blood culture media
      • Assay, kits, and reagents
      • Blood culture accessories 
    • Instruments
      • Laboratory equipment
        • Incubators
        • Colony counters
        • Microscopes
        • Gram stainers
      • Automated blood culture systems
      • Software & services
  • Blood Culture Tests Technique Outlook (Revenue, USD Million; 2014 - 2025) 
    • Conventional blood culture technique
    • Automated blood culture technique
  • Blood Culture Tests Technology Outlook (Revenue, USD Million; 2014 - 2025) 
    • Culture-based technology
    • Molecular technology
    • PCR
    • Microarray
    • PNA-FISH
    • Proteomic technology
  • Blood Culture Tests Application Outlook (Revenue, USD Million; 2014 - 2025) 
    • Bacterial infections
    • Fungal infections
    • Mycobacterial infections
  • Blood Culture Tests End-use Outlook (Revenue, USD Million; 2014 - 2025) 
    • Hospitals laboratories
    • Reference laboratories
    • Others
  • Blood Culture Tests Regional Outlook (Revenue, USD Million; 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: +1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com